Healthy Living

University of Southern California Announces Hodgkin's Lymphoma Breakthrough

Stopping the growth of lymphoma

Hodgkin Reed-Steinberg cells are considered to be one of the most notable malignant cells in classical Hodgkin's lymphoma. You could even say they "define" the disease.

By analyzing these samples, Shih and her colleagues also found that MA-O inhibitors were able to slow or sometimes even stop the growth of classical Hodgkin's lymphoma. Occasionally these results were found simply from the inhibitors, but more commonly when they were combined with whatever current treatment regimen was taking place.